Medscape Education is a proud sponsor of the inaugural 2025 Cholestatic Liver Disease Summit, taking place June 26–28 in ...

Gilead Sciences and Kymera Therapeutics have entered into a partnership worth as much as $750m to develop a molecular glue ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Accord Healthcare’s Henlius-partnered Hetronifly ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the drug be authorised to treat unresectable ...

The Considered has announced the appointment of Emily Knight-Kristoffersen as its new chief creative officer.

This is the key thing you need to know about healthcare professional (HCP) engagement – the desire for authentic human ...

June is Brain and Alzheimer’s Awareness Month — a chance to examine real-world data that links new treatments to changing clinical behavior.

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that it has become a founding member of a global ...

Johnson & Johnson (J&J) has announced that its CD38-directed antibody Darzalex (daratumumab) has been recommended by the ...

The European Commission (EC) has approved argenx’s Vyvgart (efgartigimod alfa) subcutaneous (SC) injection to treat chronic ...

That gap is precisely where Medscape Extend delivers extraordinary value; a unique approach brought to the market by Medscape in partnership with PulsePoint. Extend is an identity-based solution that ...

Jones, PhD, Clinical Strategist (Oncology) and Worldwide Patient Integration Lead to Present at the 2025 Patient Centricity & ...